Browsing by Author "c4b400f0-a048-478b-8757-b3575f73cb05"

Now showing items 1-6 of 6

    • A Pharmacogenetically Guided Acenocoumarol Dosing Algorithm for Chilean Patients: A Discovery Cohort Study 
      Roco, Ángela; Nieto, Elena; Suárez, Marcelo; Rojo, Mario; Bertoglia, María Paz; Verón, Gabriel; Tamayo, Francisca; Arredondo, Annabella; Cruz, Daniela; Muñoz, Jessica; Bravo, Gabriela; Salas, Patricio; Mejías, Fanny; Godoy, Gerald; Véliz, Paulo; Quiñones Sepúlveda, Luis (Frontiers Media, 2020)
      Background Vitamin K antagonists (VKA) are used as prophylaxis for thromboembolic events in patients with cardiovascular diseases. The most common VKA are warfarin and acenocoumarol. These drugs have a narrow therapeutic ...
    • Anticoagulation Management With Coumarinic Drugs in Chilean Patients 
      Nieto, Elena; Suarez, Marcelo; Roco, Ángela; Rubilar, Juan Carlos; Tamayo, Francisca; Rojo, Mario; Verón, Gabriel; Sepúlveda, Juliana; Mejías, Fanny; Salas, Patricio; Góngora, María; Andrade, Patricio; Canales, Alicia; Carabantes, Jorge; Cruz, Daniela; Contreras, Emma (SAGE Publications Inc., 2019)
      Warfarin and acenocoumarol are used in various cardiovascular disorders to improve the prognosis of patients with thromboembolic disease. However, there is a lack of substantial efficacy and safety data on antithrombotic ...
    • Functionally significant coumarin-related variant alleles and time to therapeutic range in chilean ... 
      Rojo, Mario; Roco Arriagada, Ángela; Suárez, Marcelo; Lavanderos Villagrán, María Alejandra; Verón, Gabriel; Bertoglia Arredondo, María Paz; Arredondo, Annabella; Nieto, Elena; Rubilar, Juan Carlos; Tamayo, Francisca; Cruz, Daniela; Muñóz, Jessica; Bravo, Gabriela; Salas, Patricio; Mejías, Fanny; Véliz, Paulo; Godoy, Gerald; Varela Figueroa, Nelson; Llull, G.; Quiñones Sepúlveda, Luis (SAGE, 2020)
      Despite the development of new oral agents over the last decade, vitamin K antagonists (VKAs) remain the most widely used anticoagulants for treating and preventing thromboembolism worldwide. In Chile, the Ministry of ...
    • Intravenous thrombolysis for ischemic stroke. Experience in 54 patients Trombolisis intravenosa en accidente ... 
      Guevara O, Carlos; Bulatova, Kateryna; Aravena, Felipe; Caba, Sheila; Monsalve, Juan; Lara, Hugo; Nieto, Elena; Navarrete, Isabel; Morales, Marcelo (Sociedad Medica de Santiago, 2016)
      © 2016, Sociedad Medica de Santiago. All Rights Reserved. Background: Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) reduces disability in patients with ischemic stroke. However, its ...
    • Management of ischemic strokes derived from intraventricular thrombi. Report of two cases Accidente ... 
      Oberreuter, Gerardo; Silva, Natalia; Caba, Sheila; Morales, Marcelo; Nieto, Elena; Guevara, Carlos (Sociedad Medica de Santiago, 2014)
      © 2014, Sociedad Medica de Santiago. All rights reserved.The origin of 20% of ischemic strokes is a left ventricular thrombus. We report two patients with strokes originating from cardiac thrombi, treated in two different ...
    • Trombolisis intravenosa en accidente cerebro vascular isquémico agudo en un hospital público de Chile: ... 
      Guevara O., Carlos; Bulatova, Kateryna; Aravena, Felipe; Caba, Sheila; Monsalve, Juan; Lara, Hugo; Nieto, Elena; Navarrete, Isabel; Morales, Marcelo (Soc Médica Santiago, 2016)
      Background: Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) reduces disability in patients with ischemic stroke. However, its implementation in Chilean public general hospitals has been ...